Reducing Cardiovascular Risk With Effective Management Of LDL Cholesterol - A Round Table Discussion

Published: 18 December 2020

  • Views:

    Views Icon 79

  • Likes:

    Heart Icon 7
  • episode_image
    2m 29s
    Part 6 Chapter 6: Summary
    Kausik (Kosh) Ray, Lale Tokgözoğlu, Christie Ballantyne
Average (ratings)
No ratings
Your rating

Overview

This round table is designed to provide clinicians with a better understanding of the long-term CV risks of LDL-C exposure. In addition to reviewing the pathogenesis of atherosclerosis and assessing the long term implications of elevated LDL-C, this meeting will consider current guidance around controlling LDL-C, the challenges in achieving LDL-C targets, and evaluate how emerging strategies are contributing to LDL-C management.

 

Each chapter will comprise of a short presentation by the named medical expert followed by a panel discussion amongst all faculty.

This medical experts round table discussion was organised independently by Radcliffe Cardiology, work that was funded by Novartis. It is intended for healthcare professionals as medical educational material, and may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities.

Learning objectives

  • Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
  • Describe the clinical challenges in achieving guideline-based LDL-C goals
  • Compare and contrast LDL-C lowering therapies

More from this programme

Part 1

Chapter 1: Welcome and introductions

1 session
Chapter 1: Welcome and introductions Watch now

Part 2

Chapter 2: The role of long-term exposure to elevated LDL-C in the pathogenesis of atherosclerosis and clinical risk

1 session
Chapter 2: The role of long-term exposure to elevated LDL-C in the pathogenesis of atherosclerosis and clinical risk Watch now

Part 3

Chapter 3: Current approaches to controlling LDL-C – what do the guidelines say?

1 session
Chapter 3: Current approaches to controlling LDL-C – what do the guidelines say? Watch now

Part 4

Chapter 4: Challenges in achieving guideline-based LDL-C targets in the real world

1 session
Chapter 4: Challenges in achieving guideline-based LDL-C targets in the real world Watch now

Part 5

Chapter 5: Contemporary approaches to managing LDL-C and cardiovascular risk

1 session
Chapter 5: Contemporary approaches to managing LDL-C and cardiovascular risk Watch now

Part 6

Chapter 6: Summary

1 session
Chapter 6: Summary Watch now

Faculty Biographies

Lale Tokgözoğlu

Lale Tokgözoğlu

Professor Cardiology, Haceteppe University, Ankara, Turkey

S. Lale Tokgözoglu is Professor of Cardiology at Hacettepe University, Ankara, Turkey. She is currently the President of the European Atherosclerosis Society and Deputy Editor of the European Heart Journal. She chaired the ‘Atherosclerosis and Vascular Biology Working Group of the European Society of Cardiology’ between 2008 and 2010. Professor Tokgözoglu has served on the Board of the Turkish Society of Cardiology and was elected to be the first female President of the Society in its history, between 2014-2016. During that time, she worked with the Ministry of Health to develop ‘Heart Health policies’ and strategies. She also chaired the Dyslipidaemia Working Group of the Turkish Society of Cardiology.

Professor Tokgözoglu has contributed to several Guidelines and Consensus Papers on dyslipidaemia and Preventive Cardiology both in Europe and nationally. She was a member of the Steering Committee of the EUROASPIRE studies and has also served on the Board of the Prevention…

View full profile